ARTICLE | Clinical News
Avelox moxifloxacin regulatory update
July 25, 2005 7:00 AM UTC
EU approved an expanded indication for Avelox IV moxifloxacin to include complicated skin and skin structure infections (cSSSI). The new indication for the fluoroquinolone antibiotic is approved in 17...